An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
An Extension of an Interventional Study to Assess the Effect of Expanded Dialysis (HDx-Theranova) on Patient Reported Symptoms Using London Evaluation of Illness (LEVIL)
Stručný súhrn
Investigators know that many patients who are on dialysis suffer from burden of unwanted symptoms, which can affect quality of life. The understanding and treatment of symptom burden by healthcare providers is limited and should be recognized as a high priority in the care of the dialysis population. In this study, the investigators will be assessing symptom burden using the London Evaluation of Illness "LEVIL," an application based platform where patients self-report their symptoms with one to three hemodialysis treatments per week for 28 weeks. The investigators would like to compare the currently available dialyzer with a new dialyzer that is capable of removing solutes of higher molecular weight that may or may not cause patients to experience symptoms related to increased amounts of toxins in their blood.
Základné údaje
| Ochorenia | End Stage Renal Disease |
|---|---|
| Intervencie | DEVICE: Theranova Dialyzer |
| Sponzor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Plánovaný počet | 100 |
| Začiatok | 2024-03-01 |
| Predp. ukončenie (primárne) | 2026-12-31 |
| Krajiny | Canada |
| Posledná aktualizácia | 2026-05-04 |